Press release
Coronary Stents Market Proliferating Opportunities, New Innovation, Development, Application Till 2028
Coronary Stents Market Outlook 2028
The global coronary stents market was valued at US$ 10.1 Bn in 2020
It is estimated to expand at a CAGR of 12.9% from 2021 to 2028
The global coronary stents market is expected to reach the value of US$ 25.7 Bn by the end of 2028
Report Overview: https://www.transparencymarketresearch.com/coronary-stents-market.html
Increase in Demand Due to Rise in Prevalence of Cardiovascular Diseases
The growing incidence of cardiovascular disorders in people across the globe is a major factor driving the coronary stents market during the forecast period. Coronary stents are tubes placed in the coronary artery to clear artery blockages or coronary artery stenosis. They are utilized in a procedure called percutaneous coronary intervention (PCI) or coronary angioplasty. This procedure is a minimally invasive procedure to treat stenosis or narrowing of the coronary arteries. Technology plays an indispensable role in the global coronary stents market. Manufacturers have been undertaking rigorous research and development initiatives to develop nascent products that are functionally superior to their previous versions.
Changes in lifestyle and need of controlling rapidly rising obesity rate are major factors for the treatment of cardio vascular disease (CVD). Percutaneous coronary intervention has become a standard treatment option preferred across the globe for CVD. Increase in awareness about the technological innovations in interventional cardiology and cost effectiveness of the procedure propel stents production.
Stringent Regulations for Product Approvals in Developing Nations
The approval of medical devices is considered to be expensive. Coronary stents fall under the category III devices of the U.S. FDA. These devices require submission and approval of pre-market approval (PMA) application prior to commercial marketing in the U.S. The requirements of clinical and pre-clinical data for stents engage the sponsor and manufacturer for a long period of time. Resources of manufacturers and investors such as time and money are spent on conducting safety testing and clinical pharmacology and toxicology testing of drug substance in case of DES. The FDA's regulatory procedures are comparatively time-consuming as compared to that of EMA. Thus, prolonged procedures of drug approval by regulatory authorities in the U.S. deter manufacturers from opting for development and commercialization of stents.
Drug Eluting Stent to be Highly Lucrative Segment
Advancements in the coronary stent technology are expected to augment the market during the forecast period. The drug eluting stent segment is expected to account for a major market share in the upcoming years. There is an increasing risk of stent thrombosis in patients after stopping the antiplatelet therapy. The management of CAD has improved to advances in the drug eluting stent (DES) technology. The advanced technology can be efficiently used to treat patients with coronary artery diseases. New materials are being developed for the treatment such as biodegradable metals, etc. Technological advancements in coronary stents and lucrative presence of manufacturers are driving the global coronary stents market growth.
Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23
North America Coronary Stents Market to Expand at Rapid Pace
North America is expected to dominate the global coronary stents market, followed by Europe and Asia Pacific nations such as Japan and China. CVDs are listed as a major cause of mortality across the world, responsible for one in every three deaths in the U.S. The occurrence of restenosis after angioplasty procedure boosts the adoption of novel stents, such as drug-eluting and bioresorbable, which are known to drastically reduce the frequency of restenosis. This factor boosts the demand for coronary stents in North America. High geriatric population, lifestyle changes leading to obesity and related health complications, and advent of advanced technologies such as bio-absorbable and next generation stents are major factors driving the North America coronary stents market.
Coronary Stents Market: Overview
According to Transparency Market Research's latest report on the global coronary stents market for the historical period 2017-2019 and forecast period from 2021 to 2028, rise in prevalence of coronary artery diseases (CADs) and increase in global obesity rate are projected to drive the global coronary stents market during the forecast period
Rise in Prevalence of Cardiovascular Diseases: Key Driver
Cardiovascular diseases (CVD) overtook cancer as the leading cause of chronic disease morbidity and mortality in the 20th Century. It has peaked and begun to fall in many countries, while it is rising in developing countries. Risk factors, sociocultural changes, and medical care all play a role in understanding these disease patterns.
According to the World Health Organization, 17.9 million people succumbed to CVDs in 2019, constituting 32% of all global deaths. Around 85% of these deaths were caused by a heart attack or a stroke.
More than three-quarters of CVD deaths occur in low- and middle-income countries. In 2019, non-communicable diseases claimed the lives of 17 million people under the age of 70, accounting for 38% of all premature deaths.
High systolic blood pressure and smoking are the first and second leading risk factors for years of life lost globally in 2019. In the same year, the first and second leading years lived with disability and injury risk factors were high fasting plasma glucose and high body mass index.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=23
Improvement in Coronary Stents Technology Boosts Market Growth
Coronary stent technology has progressed from a mechanical solution to abrupt vessel closure and elastic recoil after simple balloon angioplasty to a vector for local drug delivery and modification of coronary plaque pathophysiology. The introduction of drug-eluting stents (DES) has significantly reduced restenosis, but there is growing concern about the risk of late stent thrombosis, particularly after stopping antiplatelet therapy.
Management of coronary artery disease has improved to advances in drug eluting stent (DES) technology. They improve long-term patency rates by inhibiting restenosis through the controlled release of an antiproliferative agent, such as Paclitaxel, after deployment.
In the field of stent technology for treating patients with coronary artery disease, there has been a rapid technological advancement. As potential materials for the next generation of cardiovascular system treatment are developed, the use of biodegradable metals as implants will be revolutionized. Hence, enhancement in the coronary stents technology is expected to augment the market during the forecast period.
Stringent Regulatory Approvals to Hamper Market
Stringent regulatory approvals for coronary stents is likely to hamper market growth. The stringent regulatory environment could act as a restraint of the global coronary stents market over the next few years. Various governments and organizations establish guidelines and rules for the safer and more effective use of stents.
The European Association of Percutaneous Cardiovascular Interventions (EAPCI) provides clinical and non-clinical stent guidelines. Additionally, before approving stents, the FDA conducts a thorough systemic review of the literature as well as pre-clinical trials in human.
The Office of Combination Products (OCP) has published regulations for surgeons and physicians to use drug-eluting stents. These stringent rules for the use of stents are projected to hamper the growth of the global market.
Coronary Stents Market: Competition Landscape
This report profiles major players in the global coronary stents market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global coronary stents market is competitive, with the top 10 players accounting for major share of the market and companies focusing on research & development to produce better pharmaceutical and vaccine products for the existing diseases
Request Customization: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=23
Leading players operating in the global coronary stents market are
Abbott Laboratories Inc.
Boston Scientific Corporation
Medtronic Inc.
Johnson & Johnson
Terumo Corporation
B. Braun Melsungen AG
C. R. Bard Inc.
Cook Medical Inc.
AMG International GmbH
Biotronik SE & Co. KG
Stentys SA
and MicroPort Scientific Corporation
among others
More Trending Reports of Transparency Market Research:
Pharmaceutical Contract Sales Outsourcing (CSO) Market: https://www.transparencymarketresearch.com/europe-pharmaceutical-contract-sales-outsourcing-cso-market.html
Healthcare Biometrics for Children Market: https://www.transparencymarketresearch.com/healthcare-biometrics-for-children-market.html
Robotic Rehabilitation and Assistive Technologies Market: https://www.transparencymarketresearch.com/robotic-rehabilitation-assistive-technologies-market.html
IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: https://www.transparencymarketresearch.com/inflammatory-bowel-disease.html
Diagnostic Reagents Market: https://www.transparencymarketresearch.com/diagnostic-reagents-market.html
Thoracic Drainage Devices Market: https://www.transparencymarketresearch.com/thoracic-drainage-devices-market.html
Cell Separation Technologies Market: https://www.transparencymarketresearch.com/cell-separation-technologies.html
Personal Mobility Devices Market: https://www.transparencymarketresearch.com/personal-mobility-devices-market.html
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
About Transparency Market Research
Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End-Use that will favor growth in the market over the next 9 years.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
The global coronary stents market was valued at US$ 10.1 Bn in 2020
It is estimated to expand at a CAGR of 12.9% from 2021 to 2028
The global coronary stents market is expected to reach the value of US$ 25.7 Bn by the end of 2028
Report Overview: https://www.transparencymarketresearch.com/coronary-stents-market.html
Increase in Demand Due to Rise in Prevalence of Cardiovascular Diseases
The growing incidence of cardiovascular disorders in people across the globe is a major factor driving the coronary stents market during the forecast period. Coronary stents are tubes placed in the coronary artery to clear artery blockages or coronary artery stenosis. They are utilized in a procedure called percutaneous coronary intervention (PCI) or coronary angioplasty. This procedure is a minimally invasive procedure to treat stenosis or narrowing of the coronary arteries. Technology plays an indispensable role in the global coronary stents market. Manufacturers have been undertaking rigorous research and development initiatives to develop nascent products that are functionally superior to their previous versions.
Changes in lifestyle and need of controlling rapidly rising obesity rate are major factors for the treatment of cardio vascular disease (CVD). Percutaneous coronary intervention has become a standard treatment option preferred across the globe for CVD. Increase in awareness about the technological innovations in interventional cardiology and cost effectiveness of the procedure propel stents production.
Stringent Regulations for Product Approvals in Developing Nations
The approval of medical devices is considered to be expensive. Coronary stents fall under the category III devices of the U.S. FDA. These devices require submission and approval of pre-market approval (PMA) application prior to commercial marketing in the U.S. The requirements of clinical and pre-clinical data for stents engage the sponsor and manufacturer for a long period of time. Resources of manufacturers and investors such as time and money are spent on conducting safety testing and clinical pharmacology and toxicology testing of drug substance in case of DES. The FDA's regulatory procedures are comparatively time-consuming as compared to that of EMA. Thus, prolonged procedures of drug approval by regulatory authorities in the U.S. deter manufacturers from opting for development and commercialization of stents.
Drug Eluting Stent to be Highly Lucrative Segment
Advancements in the coronary stent technology are expected to augment the market during the forecast period. The drug eluting stent segment is expected to account for a major market share in the upcoming years. There is an increasing risk of stent thrombosis in patients after stopping the antiplatelet therapy. The management of CAD has improved to advances in the drug eluting stent (DES) technology. The advanced technology can be efficiently used to treat patients with coronary artery diseases. New materials are being developed for the treatment such as biodegradable metals, etc. Technological advancements in coronary stents and lucrative presence of manufacturers are driving the global coronary stents market growth.
Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23
North America Coronary Stents Market to Expand at Rapid Pace
North America is expected to dominate the global coronary stents market, followed by Europe and Asia Pacific nations such as Japan and China. CVDs are listed as a major cause of mortality across the world, responsible for one in every three deaths in the U.S. The occurrence of restenosis after angioplasty procedure boosts the adoption of novel stents, such as drug-eluting and bioresorbable, which are known to drastically reduce the frequency of restenosis. This factor boosts the demand for coronary stents in North America. High geriatric population, lifestyle changes leading to obesity and related health complications, and advent of advanced technologies such as bio-absorbable and next generation stents are major factors driving the North America coronary stents market.
Coronary Stents Market: Overview
According to Transparency Market Research's latest report on the global coronary stents market for the historical period 2017-2019 and forecast period from 2021 to 2028, rise in prevalence of coronary artery diseases (CADs) and increase in global obesity rate are projected to drive the global coronary stents market during the forecast period
Rise in Prevalence of Cardiovascular Diseases: Key Driver
Cardiovascular diseases (CVD) overtook cancer as the leading cause of chronic disease morbidity and mortality in the 20th Century. It has peaked and begun to fall in many countries, while it is rising in developing countries. Risk factors, sociocultural changes, and medical care all play a role in understanding these disease patterns.
According to the World Health Organization, 17.9 million people succumbed to CVDs in 2019, constituting 32% of all global deaths. Around 85% of these deaths were caused by a heart attack or a stroke.
More than three-quarters of CVD deaths occur in low- and middle-income countries. In 2019, non-communicable diseases claimed the lives of 17 million people under the age of 70, accounting for 38% of all premature deaths.
High systolic blood pressure and smoking are the first and second leading risk factors for years of life lost globally in 2019. In the same year, the first and second leading years lived with disability and injury risk factors were high fasting plasma glucose and high body mass index.
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=23
Improvement in Coronary Stents Technology Boosts Market Growth
Coronary stent technology has progressed from a mechanical solution to abrupt vessel closure and elastic recoil after simple balloon angioplasty to a vector for local drug delivery and modification of coronary plaque pathophysiology. The introduction of drug-eluting stents (DES) has significantly reduced restenosis, but there is growing concern about the risk of late stent thrombosis, particularly after stopping antiplatelet therapy.
Management of coronary artery disease has improved to advances in drug eluting stent (DES) technology. They improve long-term patency rates by inhibiting restenosis through the controlled release of an antiproliferative agent, such as Paclitaxel, after deployment.
In the field of stent technology for treating patients with coronary artery disease, there has been a rapid technological advancement. As potential materials for the next generation of cardiovascular system treatment are developed, the use of biodegradable metals as implants will be revolutionized. Hence, enhancement in the coronary stents technology is expected to augment the market during the forecast period.
Stringent Regulatory Approvals to Hamper Market
Stringent regulatory approvals for coronary stents is likely to hamper market growth. The stringent regulatory environment could act as a restraint of the global coronary stents market over the next few years. Various governments and organizations establish guidelines and rules for the safer and more effective use of stents.
The European Association of Percutaneous Cardiovascular Interventions (EAPCI) provides clinical and non-clinical stent guidelines. Additionally, before approving stents, the FDA conducts a thorough systemic review of the literature as well as pre-clinical trials in human.
The Office of Combination Products (OCP) has published regulations for surgeons and physicians to use drug-eluting stents. These stringent rules for the use of stents are projected to hamper the growth of the global market.
Coronary Stents Market: Competition Landscape
This report profiles major players in the global coronary stents market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global coronary stents market is competitive, with the top 10 players accounting for major share of the market and companies focusing on research & development to produce better pharmaceutical and vaccine products for the existing diseases
Request Customization: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=23
Leading players operating in the global coronary stents market are
Abbott Laboratories Inc.
Boston Scientific Corporation
Medtronic Inc.
Johnson & Johnson
Terumo Corporation
B. Braun Melsungen AG
C. R. Bard Inc.
Cook Medical Inc.
AMG International GmbH
Biotronik SE & Co. KG
Stentys SA
and MicroPort Scientific Corporation
among others
More Trending Reports of Transparency Market Research:
Pharmaceutical Contract Sales Outsourcing (CSO) Market: https://www.transparencymarketresearch.com/europe-pharmaceutical-contract-sales-outsourcing-cso-market.html
Healthcare Biometrics for Children Market: https://www.transparencymarketresearch.com/healthcare-biometrics-for-children-market.html
Robotic Rehabilitation and Assistive Technologies Market: https://www.transparencymarketresearch.com/robotic-rehabilitation-assistive-technologies-market.html
IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: https://www.transparencymarketresearch.com/inflammatory-bowel-disease.html
Diagnostic Reagents Market: https://www.transparencymarketresearch.com/diagnostic-reagents-market.html
Thoracic Drainage Devices Market: https://www.transparencymarketresearch.com/thoracic-drainage-devices-market.html
Cell Separation Technologies Market: https://www.transparencymarketresearch.com/cell-separation-technologies.html
Personal Mobility Devices Market: https://www.transparencymarketresearch.com/personal-mobility-devices-market.html
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
About Transparency Market Research
Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End-Use that will favor growth in the market over the next 9 years.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
